Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hong

Showing results (781-790 of 1,190) with videos related to

Pageof 119
Sort By:
Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.
International Journal of Cardiology|July 16, 2014
Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta-analysis, D A Healy, W A Khan, et al.
Intensive Care Medicine|June 24, 2020
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinionPaul E Verweij, Bart J A Rijnders, Roger J M Brüggemann, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2022
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue SarcomaSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2023
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 TrialRaphael Koch, Lianne Haveman, Ruth Ladenstein, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015: results from a multicenter, retrospective study]Y K Wan, W Sang, B Chen, et al.
Journal of Clinical Microbiology|November 11, 2024
Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminologySybren de Hoog, Thomas J Walsh, Sarah A Ahmed, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 19, 2026
International Dermoscopy Society consensus recommendations for the management of lentigo malignaAna-Maria Forsea, Riccardo Pampena, Bengu Nisa Akay, et al.
Pathology|December 23, 2021
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingRichard A Scolyer, Victoria Atkinson, David E Gyorki, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Pageof 119

Showing results (781-790 of 1,190) with videos related to

Sort By:
Pageof 119
Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.
International Journal of Cardiology|July 16, 2014
Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta-analysis, D A Healy, W A Khan, et al.
Intensive Care Medicine|June 24, 2020
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinionPaul E Verweij, Bart J A Rijnders, Roger J M Brüggemann, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2022
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue SarcomaSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2023
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 TrialRaphael Koch, Lianne Haveman, Ruth Ladenstein, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015: results from a multicenter, retrospective study]Y K Wan, W Sang, B Chen, et al.
Journal of Clinical Microbiology|November 11, 2024
Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminologySybren de Hoog, Thomas J Walsh, Sarah A Ahmed, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 19, 2026
International Dermoscopy Society consensus recommendations for the management of lentigo malignaAna-Maria Forsea, Riccardo Pampena, Bengu Nisa Akay, et al.
Pathology|December 23, 2021
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingRichard A Scolyer, Victoria Atkinson, David E Gyorki, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Pageof 119